Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pfister

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
BJU International|June 19, 2024
Trophoblast cell surface antigen-2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinomaRichard Weiten, Enno Storz, Carolina Kessler, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2005
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experienceFernando F de Arruda, Dev R Puri, Joanne Zhung, et al.
Head & Neck|July 24, 2024
Outcomes of SMARCB1-deficient sinonasal carcinoma: Largest single-center cross-sectional studyRobbie Woods, Daniel Scholfield, Lucas Axiotakis, et al.
Urologic Oncology|October 2, 2024
Multivariate analysis of the parameters affecting the choice of surgical treatment for patients with localized renal cell carcinoma (RCC)Maksym Pikul, Oleg Voylenko, Oleksandr Stakhovskyi, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2010
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancerLawrence Koutcher, Eric Sherman, Matthew Fury, et al.
World Journal of Urology|September 15, 2022
Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic reviewChristian G Ruf, Stefanie Schmidt, Sabine Kliesch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinomaIan Ganly, Simon Talbot, Diane Carlson, et al.
International Journal of Molecular Sciences|February 13, 2020
<i>ITIH5</i> and <i>ECRG4</i> DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder CancerMichael Rose, Sarah Bringezu, Laura Godfrey, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 17, 2025
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCCGabriel Raab, Bin Xu, Anas Alabkaa, et al.
Biomed Research International|February 11, 2015
Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MSCordelia Geisler, Nadine T Gaisa, David Pfister, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
BJU International|June 19, 2024
Trophoblast cell surface antigen-2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinomaRichard Weiten, Enno Storz, Carolina Kessler, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2005
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experienceFernando F de Arruda, Dev R Puri, Joanne Zhung, et al.
Head & Neck|July 24, 2024
Outcomes of SMARCB1-deficient sinonasal carcinoma: Largest single-center cross-sectional studyRobbie Woods, Daniel Scholfield, Lucas Axiotakis, et al.
Urologic Oncology|October 2, 2024
Multivariate analysis of the parameters affecting the choice of surgical treatment for patients with localized renal cell carcinoma (RCC)Maksym Pikul, Oleg Voylenko, Oleksandr Stakhovskyi, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2010
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancerLawrence Koutcher, Eric Sherman, Matthew Fury, et al.
World Journal of Urology|September 15, 2022
Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic reviewChristian G Ruf, Stefanie Schmidt, Sabine Kliesch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinomaIan Ganly, Simon Talbot, Diane Carlson, et al.
International Journal of Molecular Sciences|February 13, 2020
<i>ITIH5</i> and <i>ECRG4</i> DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder CancerMichael Rose, Sarah Bringezu, Laura Godfrey, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 17, 2025
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCCGabriel Raab, Bin Xu, Anas Alabkaa, et al.
Biomed Research International|February 11, 2015
Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MSCordelia Geisler, Nadine T Gaisa, David Pfister, et al.
Pageof 20